Publicacions en col·laboració amb investigadors/es de Universidad del País Vasco/Euskal Herriko Unibertsitatea (22)

2024

  1. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2023

  1. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

2022

  1. A Ca2+-Dependent Mechanism Boosting Glycolysis and OXPHOS by Activating Aralar-Malate-Aspartate Shuttle, upon Neuronal Stimulation

    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 42, Núm. 19, pp. 3879-3895

  2. Electroactive 3D printable poly(3,4-ethylenedioxythiophene)-: Graft -poly(ϵ-caprolactone) copolymers as scaffolds for muscle cell alignment

    Polymer Chemistry, Vol. 13, Núm. 1, pp. 109-120

2021

  1. 3D Printable Conducting and Biocompatible PEDOT-graft-PLA Copolymers by Direct Ink Writing

    Macromolecular Rapid Communications, Vol. 42, Núm. 12

  2. Discovery of a novel family of FKBP12 “reshapers” and their use as calcium modulators in skeletal muscle under nitro-oxidative stress

    European Journal of Medicinal Chemistry, Vol. 213

  3. Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 6, pp. 711-723

2020

  1. A genotyping method combining primer competition PCR with HRM analysis to identify point mutations in Duchenne animal models

    Scientific Reports, Vol. 10, Núm. 1

  2. In vitro human skeletal muscle platform for the evaluation of functional outcomes

    XXXVIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. CASEIB 2020: Libro de actas

2019

  1. COST Actions: fostering collaborative research for rare diseases

    The Lancet Neurology

  2. Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations

    International Journal of Molecular Sciences, Vol. 20, Núm. 18

2017

  1. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis

    Expert Reviews in Molecular Medicine, Vol. 19

2016

  1. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle

    Expert Reviews in Molecular Medicine, Vol. 18

2013

  1. Junctophilins and μ-calpain: Partners in excitation-contraction uncoupling

    Journal of Physiology

2006

  1. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients

    Schizophrenia Research

  2. GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation

    Journal of Neurochemistry, Vol. 99, Núm. 1, pp. 134-141

  3. Increased expression and function of glutamate transporters in multiple sclerosis

    Neurobiology of Disease, Vol. 21, Núm. 1, pp. 154-164

2005

  1. A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake

    Journal of Neurochemistry, Vol. 95, Núm. 2, pp. 341-348

  2. Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures

    GLIA, Vol. 50, Núm. 3, pp. 276-279

  3. Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics

    GLIA, Vol. 49, Núm. 3, pp. 451-455